Free Trial

Credit Agricole S A Has $8.55 Million Holdings in DaVita Inc. $DVA

DaVita logo with Medical background

Key Points

  • Credit Agricole S A sold 70,213 shares of DaVita Inc., reducing its holdings by 55.7% to approximately 55,885 shares valued at $8.55 million.
  • DaVita reported earnings of $2.95 per share, exceeding analyst estimates by $0.25, with quarterly revenue increasing by 6.1% year-over-year to $3.38 billion.
  • Wall Street analysts have diverse opinions on DaVita, with a consensus rating of "Hold" and target price revisions varying from $148 to $160.
  • Interested in DaVita? Here are five stocks we like better.

Credit Agricole S A cut its holdings in DaVita Inc. (NYSE:DVA - Free Report) by 55.7% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 55,885 shares of the company's stock after selling 70,213 shares during the quarter. Credit Agricole S A owned about 0.07% of DaVita worth $8,549,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the business. Wealth Enhancement Advisory Services LLC boosted its stake in DaVita by 2.0% in the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 3,551 shares of the company's stock valued at $531,000 after acquiring an additional 69 shares during the last quarter. UMB Bank n.a. boosted its position in shares of DaVita by 65.5% during the first quarter. UMB Bank n.a. now owns 192 shares of the company's stock worth $29,000 after purchasing an additional 76 shares in the last quarter. Exchange Traded Concepts LLC boosted its position in shares of DaVita by 8.9% during the first quarter. Exchange Traded Concepts LLC now owns 970 shares of the company's stock worth $148,000 after purchasing an additional 79 shares in the last quarter. Mather Group LLC. boosted its position in shares of DaVita by 7.0% during the first quarter. Mather Group LLC. now owns 1,201 shares of the company's stock worth $184,000 after purchasing an additional 79 shares in the last quarter. Finally, National Pension Service boosted its position in shares of DaVita by 74.3% during the first quarter. National Pension Service now owns 197 shares of the company's stock worth $30,000 after purchasing an additional 84 shares in the last quarter. 90.12% of the stock is owned by institutional investors.

DaVita Stock Performance

NYSE DVA traded up $0.18 during trading on Wednesday, reaching $138.86. The company's stock had a trading volume of 75,426 shares, compared to its average volume of 854,708. The firm has a 50 day moving average price of $139.66 and a 200 day moving average price of $143.41. The firm has a market capitalization of $9.93 billion, a price-to-earnings ratio of 13.66, a price-to-earnings-growth ratio of 0.98 and a beta of 1.09. The company has a current ratio of 1.39, a quick ratio of 1.34 and a debt-to-equity ratio of 23.18. DaVita Inc. has a 12 month low of $126.07 and a 12 month high of $179.60.

DaVita (NYSE:DVA - Get Free Report) last released its quarterly earnings data on Tuesday, August 5th. The company reported $2.95 earnings per share for the quarter, beating the consensus estimate of $2.70 by $0.25. The business had revenue of $3.38 billion for the quarter, compared to analyst estimates of $3.36 billion. DaVita had a return on equity of 369.39% and a net margin of 6.35%.DaVita's revenue was up 6.1% compared to the same quarter last year. During the same period last year, the firm posted $2.00 earnings per share. DaVita has set its FY 2025 guidance at 10.200-11.300 EPS. As a group, equities analysts anticipate that DaVita Inc. will post 10.76 EPS for the current fiscal year.

Insider Transactions at DaVita

In other DaVita news, insider James O. Hearty sold 2,351 shares of the company's stock in a transaction that occurred on Wednesday, July 23rd. The shares were sold at an average price of $150.00, for a total value of $352,650.00. Following the completion of the transaction, the insider directly owned 26,038 shares in the company, valued at approximately $3,905,700. This represents a 8.28% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Company insiders own 1.50% of the company's stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently commented on DVA shares. Truist Financial set a $148.00 price objective on shares of DaVita in a report on Friday, August 8th. Wall Street Zen upgraded shares of DaVita from a "hold" rating to a "buy" rating in a report on Friday, August 22nd. Finally, Barclays dropped their price objective on shares of DaVita from $169.00 to $160.00 and set an "equal weight" rating on the stock in a report on Thursday, August 7th. Three analysts have rated the stock with a Hold rating, According to MarketBeat.com, the company has a consensus rating of "Hold" and a consensus target price of $164.00.

Read Our Latest Stock Report on DaVita

About DaVita

(Free Report)

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.

Further Reading

Institutional Ownership by Quarter for DaVita (NYSE:DVA)

Should You Invest $1,000 in DaVita Right Now?

Before you consider DaVita, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DaVita wasn't on the list.

While DaVita currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report
Like this article? Share it with a colleague.